Spirepoint Private Client’s Medtronic MDT Stock Holding History

Spirepoint Private Client’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Sell	4,060 -688	-14%	-$65.9K	0.03%	233
2025 Q4	$456K	Buy	4,748 +693	+17%	+$67.3K	0.04%	184
2025 Q3	$386K	Buy	4,055 +156	+4%	+$14.3K	0.04%	190
2025 Q2	$340K	Hold	3,899	–	–	0.04%	183
2025 Q1	$350K	Sell	3,899 -2,525	-39%	-$226K	0.05%	164
2024 Q4	$513K	Sell	6,424 -34,733	-84%	-$3.01M	0.06%	143
2024 Q3	$3.71M	Buy	41,157 +5,344	+15%	+$450K	0.49%	51
2024 Q2	$2.82M	Buy	35,813 +4,609	+15%	+$378K	0.4%	55
2024 Q1	$2.72M	Buy	+31,204	New	+$2.66M	0.41%	52

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spirepoint Private Client's MDT Position: Q1 2026 in Review

Spirepoint Private Client reduced its Medtronic (MDT) stake by 14% in Q1 2026, selling an estimated $65.9K and leaving 4,060 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #233.

Spirepoint Private Client first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.71M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Spirepoint Private Client held 4,060 shares of Medtronic worth $352K as of Q1 2026.
Spirepoint Private Client sold 688 Medtronic shares in Q1 2026, an estimated $65.9K.
Medtronic made up 0.03% of Spirepoint Private Client's portfolio in Q1 2026, its #233 holding.
Spirepoint Private Client first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
Spirepoint Private Client's Medtronic position peaked at $3.71M in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.